Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP496752.RAD0Idx2JSAbFhPRyWNeUfE9vTiCBcJjU5VF8m9foF_Kw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP496752.RAD0Idx2JSAbFhPRyWNeUfE9vTiCBcJjU5VF8m9foF_Kw130_assertion type Assertion NP496752.RAD0Idx2JSAbFhPRyWNeUfE9vTiCBcJjU5VF8m9foF_Kw130_head.
- NP496752.RAD0Idx2JSAbFhPRyWNeUfE9vTiCBcJjU5VF8m9foF_Kw130_assertion description "[36.6% of the patients with MDS and myelofibrosis developed a transformation into ANLL during the course of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496752.RAD0Idx2JSAbFhPRyWNeUfE9vTiCBcJjU5VF8m9foF_Kw130_provenance.
- NP496752.RAD0Idx2JSAbFhPRyWNeUfE9vTiCBcJjU5VF8m9foF_Kw130_assertion evidence source_evidence_literature NP496752.RAD0Idx2JSAbFhPRyWNeUfE9vTiCBcJjU5VF8m9foF_Kw130_provenance.
- NP496752.RAD0Idx2JSAbFhPRyWNeUfE9vTiCBcJjU5VF8m9foF_Kw130_assertion SIO_000772 1592101 NP496752.RAD0Idx2JSAbFhPRyWNeUfE9vTiCBcJjU5VF8m9foF_Kw130_provenance.
- NP496752.RAD0Idx2JSAbFhPRyWNeUfE9vTiCBcJjU5VF8m9foF_Kw130_assertion wasDerivedFrom befree-2016 NP496752.RAD0Idx2JSAbFhPRyWNeUfE9vTiCBcJjU5VF8m9foF_Kw130_provenance.
- NP496752.RAD0Idx2JSAbFhPRyWNeUfE9vTiCBcJjU5VF8m9foF_Kw130_assertion wasGeneratedBy ECO_0000203 NP496752.RAD0Idx2JSAbFhPRyWNeUfE9vTiCBcJjU5VF8m9foF_Kw130_provenance.